← back to search

Chao Gao

Huawei Technologies (Canada) · CA
Area of research
Public Health, Environmental and Occupational Health · Hematology
Research interest
Research interests include Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Childhood Cancer Survivors' Quality of Life, and Chronic Myeloid Leukemia Treatments.
h-index
24
citations
1,908
works
145
NIH funding
primary concept
email

Recent publications

Acute ataxia in children: etiological spectrum and clinical characteristics
Frontiers in Pediatrics 2025cited by 1position: middledoi
Homoharringtonine-Based Induction Regimen Improved the Remission Rate and Survival Rate in Chinese Childhood AML: A Report From the CCLG-AML 2015 Protocol Study
Journal of Clinical Oncology 2023cited by 31position: middledoi
Melatonin suppresses sympathetic vasomotor tone through enhancing GABAA receptor activity in the hypothalamus
Frontiers in Physiology 2023cited by 21position: middledoi
Combined analysis of PHOX2B at two time points and its value for further risk stratification in high‐risk neuroblastoma
Pediatric Blood & Cancer 2023cited by 9position: middledoi
<scp>MYCN</scp> amplification plus 1p36 loss of heterozygosity predicts ultra high risk in bone marrow metastatic neuroblastoma
Cancer Medicine 2022cited by 16position: middledoi
NRBP1 negatively regulates SALL4 to reduce the invasion and migration, promote apoptosis and increase the sensitivity to chemotherapy drugs of breast cancer cells
Oncology Letters 2022cited by 8position: middledoi
A phase ib trial of assessing the safety and preliminary efficacy of a combination therapy of geptanolimab (GB 226) plus fruquintinib in patients with metastatic colorectal cancer (mCRC).
Journal of Clinical Oncology 2021cited by 12position: middledoi
Pembrolizumab (pembro) for advanced biliary adenocarcinoma: Results from the KEYNOTE-028 (KN028) and KEYNOTE-158 (KN158) basket studies.
Journal of Clinical Oncology 2019cited by 132position: middledoi
Homocysteine-methionine cycle is a metabolic sensor system controlling methylation-regulated pathological signaling
Redox Biology 2019cited by 107position: middledoi
Effect of micro<scp>RNA</scp>‐210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia
Cancer Science 2014cited by 55position: middledoi
Chronic intermittent hypobaric hypoxia prevents cardiac dysfunction through enhancing antioxidation in fructose-fed rats
Canadian Journal of Physiology and Pharmacology 2013cited by 27position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Zhixia Yue · Ministry of Education of the People's Republic of China2 papers (2022–2023)Wen Zhao · Tianjin University of Traditional Chinese Medicine2 papers (2022–2023)Tianyu Xing · Ministry of Education of the People's Republic of China2 papers (2022–2023)Yan Su · Ministry of Education of the People's Republic of China2 papers (2022–2023)Makoto Ueno · Wakayama Medical University1 papers (2019–2019)Yung‐Jue Bang · Seoul National University1 papers (2019–2019)Kevin Norwood · Allogene Therapeutics (United States)1 papers (2019–2019)Wen Shen · Nanchang University1 papers (2019–2019)Antoîne Italiano · Institut Bergonié1 papers (2019–2019)Chao Yang · Guangzhou University of Chinese Medicine1 papers (2022–2022)Hangfei Fu · Thomas Jefferson University1 papers (2019–2019) · 1 papers (2021–2021)Adnan Nagrial · Westmead Hospital1 papers (2019–2019)Qi Guo · Hebei Medical University1 papers (2023–2023)Chao Duan · Ministry of Education of the People's Republic of China1 papers (2023–2023)De‐Pei Li · Sun Yat-sen University Cancer Center1 papers (2023–2023)Kaiye Du · Hebei Medical University1 papers (2022–2022)Yuxian Bai · Harbin Medical University1 papers (2021–2021) · 1 papers (2014–2014)Yunjiang Liu · Hebei Medical University1 papers (2022–2022)